Inhibitors of kallikrein in human plasma
- PMID: 4113391
- PMCID: PMC292308
- DOI: 10.1172/jci106962
Inhibitors of kallikrein in human plasma
Abstract
Human plasma was fractionated by ammonium sulfate precipitation, DEAE-cellulose chromatography, and Sephadex G-200 gel filtration to determine which method would give the greatest number of clearly separable kallikrein inhibitory peaks. With G-200 gel filtration three peaks could be separated which were demonstrated to contain alpha(2)-macroglobulin, C1 inactivator, and alpha(1)-antitrypsin. No other kallikrein inhibitors could be identified. The fractions containing C1 inactivator and alpha(2)-macroglobulin appeared to be more effective against kallikrein than that containing alpha(1)-antitrypsin. A patient with hereditary angioneurotic edema was shown to have an abnormal C1 inactivator protein capable of interfering with kallikrein's biologic, but not its esterolytic activity. Heat-treated human plasma, a commonly used source of kininogen for experiments with kallikrein, was shown to have kallikrein inhibitory activity.
Similar articles
-
Human plasma alpha 2-macroglobulin. An inhibitor of plasma kallikrein.J Exp Med. 1970 Aug 1;132(2):329-52. doi: 10.1084/jem.132.2.329. J Exp Med. 1970. PMID: 4101346 Free PMC article.
-
Separation of plasma thromboplastin antecedent from kallikrein by the plasma 2 -macroglobulin, kallikrein inhibitor.J Clin Invest. 1971 Oct;50(10):2084-90. doi: 10.1172/JCI106702. J Clin Invest. 1971. PMID: 5165598 Free PMC article.
-
Immunochemical studies of plasma kallikrein.J Clin Invest. 1974 Dec;54(6):1444-54. doi: 10.1172/JCI107892. J Clin Invest. 1974. PMID: 4140197 Free PMC article.
-
Tissue kallikrein inhibitors in mammals.Immunopharmacology. 1996 May;32(1-3):67-72. doi: 10.1016/0162-3109(96)00010-0. Immunopharmacology. 1996. PMID: 8796269 Review.
-
Discovery of highly potent small molecule kallikrein inhibitors.Med Chem. 2006 Nov;2(6):545-53. doi: 10.2174/1573406410602060545. Med Chem. 2006. PMID: 17105435 Review.
Cited by
-
Inactivation of kallikrein in human plasma.J Clin Invest. 1983 Jan;71(1):149-58. doi: 10.1172/jci110743. J Clin Invest. 1983. PMID: 6184384 Free PMC article.
-
The effect of dilution, pH and ionic strength of plasma on t-PA precipitation in euglobulin fraction.Korean J Intern Med. 1992 Jul;7(2):73-80. doi: 10.3904/kjim.1992.7.2.73. Korean J Intern Med. 1992. PMID: 1306075 Free PMC article.
-
Plasma inhibitors of the components of the fibrinolytic pathway in man.J Clin Invest. 1973 Jun;52(6):1394-401. doi: 10.1172/JCI107312. J Clin Invest. 1973. PMID: 4122174 Free PMC article.
-
Contribution of plasma protease inhibitors to the inactivation of kallikrein in plasma.J Clin Invest. 1982 Feb;69(2):462-8. doi: 10.1172/jci110470. J Clin Invest. 1982. PMID: 6173399 Free PMC article.
-
Prostate-specific antigen kallikrein and the heart.World J Cardiol. 2009 Dec 31;1(1):23-5. doi: 10.4330/wjc.v1.i1.23. World J Cardiol. 2009. PMID: 21160572 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources